Insider Transactions in Q3 2024 at Quest Diagnostics Inc (DGX)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 24
2024
|
Mark A Gardner SVP of Molecular Gen & Oncol |
SELL
Payment of exercise price or tax liability
|
Direct |
120
-2.5%
|
$18,600
$155.7 P/Share
|
|
Aug 29
2024
|
Michael E Prevoznik SVP & General Counsel |
SELL
Open market or private sale
|
Direct |
32,551
-45.83%
|
$5,012,854
$154.97 P/Share
|
|
Aug 29
2024
|
Michael E Prevoznik SVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
32,551
+31.43%
|
$3,092,345
$95.8 P/Share
|
|
Aug 28
2024
|
Karthik Kuppusamy SVP, Clinical Solutions |
SELL
Open market or private sale
|
Direct |
1,990
-14.8%
|
$304,470
$153.26 P/Share
|
|
Aug 14
2024
|
Karthik Kuppusamy SVP, Clinical Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
74
-0.55%
|
$11,026
$149.46 P/Share
|
|
Jul 24
2024
|
Mark E Delaney SVP & Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
420
-7.72%
|
$60,060
$143.08 P/Share
|
|
Jul 22
2024
|
Vicky B Gregg Director |
BUY
Small Acquisition
|
Direct |
77
+0.43%
|
$11,242
$146.97 P/Share
|
|
Jul 22
2024
|
Patrick Plewman SVP for Diagnostic Services |
BUY
Small Acquisition
|
Direct |
60
+0.37%
|
$8,760
$146.97 P/Share
|
|
Jul 22
2024
|
Karthik Kuppusamy SVP, Clinical Solutions |
BUY
Small Acquisition
|
Direct |
31
+0.23%
|
$4,526
$146.97 P/Share
|
|
Jul 22
2024
|
Sam Samad Executive Vice President & CFO |
BUY
Small Acquisition
|
Direct |
21
+0.12%
|
$3,066
$146.97 P/Share
|
|
Jul 22
2024
|
Mark E Delaney SVP & Chief Commercial Officer |
BUY
Small Acquisition
|
Direct |
6
+0.11%
|
$876
$146.98 P/Share
|
|
Jul 16
2024
|
Sam Samad Executive Vice President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,910
-18.31%
|
$555,220
$142.65 P/Share
|